Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Phosphodiesterase inhibitors in psychiatric disorders
Mohammad Amin Sadeghi, Ehsan Nassireslami, Mojtaba Yousefi Zoshk, et al.
Psychopharmacology (2023) Vol. 240, Iss. 6, pp. 1201-1219
Closed Access | Times Cited: 21

Showing 21 citing articles:

cAMP-PKA/EPAC signaling and cancer: the interplay in tumor microenvironment
Hongying Zhang, Yongliang Liu, Jieya Liu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 35
cAMP-PKA signaling pathway and anxiety: Where do we go next?
Daokang Chen, Jingji Wang, Jian Cao, et al.
Cellular Signalling (2024) Vol. 122, pp. 111311-111311
Closed Access | Times Cited: 7
Negative Symptoms in Schizophrenia: An Update on Research Assessment and the Current and Upcoming Treatment Landscape
Preetika Govil, Joshua T. Kantrowitz
CNS Drugs (2025)
Closed Access
Modulation of Cognitive Activity by Plant-Based Extracts (Allium cepa, Coffea robusta, and Brassica oleracea) through the Phosphodiesterase 4B inhibition: Insite from a Mice Model Study
Nazir Ahmad, Kaisun Nesa Lesa, Nanang Fakhrudin, et al.
Phytomedicine Plus (2025), pp. 100778-100778
Open Access
PDE7 as a Precision Target: Bridging Disease Modulation and Potential PET Imaging for Translational Medicine
Tao-Qian Zhao, Steven H. Liang
ACS Medicinal Chemistry Letters (2025)
Open Access
PHOSPHODIESTERASE INHIBITORS FOR TREATMENT OF ALZHEIMER'S DISEASE
Phool Chandra, Vikas Sharma
INDIAN DRUGS (2024) Vol. 61, Iss. 07, pp. 7-22
Closed Access | Times Cited: 3
Bile acid signalling and its role in anxiety disorders
Simin Chen, Qi Shao, Jiayi Chen, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 9
Molecular overlaps of neurological manifestations of COVID-19 and schizophrenia from a proteomic perspective
André Saraiva Leão Marcelo Antunes, Guilherme Reis‐de‐Oliveira, Daniel Martins‐de‐Souza
European Archives of Psychiatry and Clinical Neuroscience (2024)
Closed Access | Times Cited: 2
Research progress on phosphodiesterase 4 inhibitors in central nervous system diseases
Abudurousuli Adili, Aerken Dilihumaer, Huhu Zhu, et al.
Journal of Zhejiang University (Medical Sciences) (2024)
Open Access | Times Cited: 1
Putative Pharmacological Depression and Anxiety-Related Targets of Calcitriol Explored by Network Pharmacology and Molecular Docking
Bruna R. Kouba, Glorister A. Altê, Ana Lúcia S. Rodrigues
Pharmaceuticals (2024) Vol. 17, Iss. 7, pp. 893-893
Open Access | Times Cited: 1
Evaluating the potential effects of apigenin on memory, anxiety, and social interaction amelioration after social isolation stress
Ali Mohammadkhanizadeh, Yasaman Hosseini, Farnaz Nikbakht, et al.
International Journal of Developmental Neuroscience (2024)
Closed Access | Times Cited: 1
Causes and countermeasures for the increased infection and COVID-19 mortality rates in patients with schizophrenia
Zhen-Ying Li, Yuqian Li, Jingru Zhou, et al.
IBRO Neuroscience Reports (2024) Vol. 17, pp. 456-462
Open Access | Times Cited: 1
The efficacy and safety of sodium nitroprusside in the treatment of schizophrenia: a meta-analysis
Xinxing Fei, Jiyang Li, Shiqi Wang, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 3
Phosphodiesterase 7 inhibitor reduces stress-induced behavioral and cytoarchitectural changes in C57BL/6J mice by activating the BDNF/TrkB pathway
Jiahao Dong, Ran Wei, Fangjiao Zong, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Enoximone alleviates atopic dermatitis-like skin inflammation via inhibition of type 2 T helper cell development
Jin Yong Song, Jun Hyung Lee, Su Hyun Lee, et al.
International Immunopharmacology (2024) Vol. 142, pp. 113189-113189
Closed Access
Drug Repurposing Patent Applications July–September 2024
Hermann AM Mucke
Assay and Drug Development Technologies (2024)
Closed Access
Selectivity mechanism of inhibition towards Phosphodiesterase 1B and Phosphodiesterase 10A in silico investigation
Jianheng Li, Pengfei Song, Hanxun Wang, et al.
Computational Biology and Chemistry (2024) Vol. 115, pp. 108322-108322
Closed Access
Bipolar and schizophrenia risk gene AKAP11 encodes an autophagy receptor coupling the regulation of PKA kinase network homeostasis to synaptic transmission
You-Kyung Lee, Xiao Cong, Xiaoting Zhou, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Recent applications of positron emission tomographic (PET) imaging in psychiatric drug discovery
Luc Zimmer
Expert Opinion on Drug Discovery (2023) Vol. 19, Iss. 2, pp. 161-172
Closed Access | Times Cited: 1
Psychopharmacological treatment of depression and anxiety and their different drug delivery targets
Aditya Sharma, Md. Aftab Alam, Awaneet Kaur, et al.
Current Psychiatry Research and Reviews (2023) Vol. 20, Iss. 4, pp. 297-322
Closed Access
Natural and Synthetic Phosphodiesterase Inhibitors in 2023: an Update on the Impact on Neurological and Psychiatric Conditions
Giovanni Ribaudo, Alessandra Gianoncelli
Mini-Reviews in Medicinal Chemistry (2023) Vol. 24, Iss. 6, pp. 568-570
Closed Access
Page 1

Scroll to top